Global Biologics Drug Development Market

Focus on Facility, Service, Product Type, Country Analysis, and Market Dynamics - Analysis and Forecast, 2018-2027

Published Year: 2018
SKU: BH00304SB

5000

Online Access for One Person. Permission to Print

Table of Contents

1 Market Overview

         1.1    Biologics Drug Development
         1.2    Biologics Drug Development: Key Trends
         1.3    Integrated Discovery, Development, and commercialization of Biologics
         1.4    Clinical Developmental Stages of Biologics
         1.5    Manufacturing Stages of Biologics
         1.6    Process Development
         1.7    Bio Manufacturing Process
         1.8    Formulation Development
         1.9    Biologics In-House Drug Development Market
                  1.9.1    North America
                  1.9.2    Europe
                  1.9.3    Asia-Pacific
        1.10   Biologics Outsourcing  Drug Development Market
                  1.10.1    North America
                  1.10.2    Europe
                  1.10.3    Asia-Pacific
        1.11   Biologics Drug Development Cost

2 Market Dynamics

         2.1    Market Drivers
         2.2    Market Restraints
         2.3    Market Opportunities

3 Competitive Landscape

         3.1    Key Developmental Strategies
                  3.1.1    Acquisitions
                  3.1.2    Agreements, Partnership, Collaboration and Joint Ventures
                  3.1.3    Approvals
                  3.1.4.   Clinical Study
                  3.1.5    Business Expansion
                  3.1.6    Product Launch
                  3.1.7    Awards
         3.2    Porter’s Five Forces Analysis

4 Biologics Drug Development Market, (by Class)

         4.1    Overview
                  4.1.1    Monoclonal Antibodies (mAbs)
                  4.1.2    Hormones
                  4.1.3    Growth Factors
                  4.1.4    Cytokines and Fusion Proteins
                  4.1.5    Therapeutic Enzymes
                  4.1.6    Blood Factors and Anticoagulants
                  4.1.7    Vaccines

5 Biologics Drug Development Market, (by Facility)

          5.1    Overview
                   5.1.1    In-House
                   5.1.2    Outsource
                   5.1.3    Pharma Excess

6 Biologics Drug Development Market, (by Services)

         6.1    Overview
                  6.1.1    Clinical Manufacturing
                              6.1.1.1    Cell Bank Preparation and Cell Line Development
                              6.1.1.2    Cell Culture Upstream Development
                              6.1.1.3    Purification Downstream Development
                  6.1.2    Formulation Development
                  6.1.3    Bioassay Development
                  6.1.4    Analytical Services

7 Biologics Drug Development Market, (by Region)

         7.1    Global Scenario
         7.2    North America
                  7.2.1    The U.S.
                  7.2.2    Canada
         7.3    Europe
                  7.3.1    The U.K.
                  7.3.2    Germany
                  7.3.3    France
                  7.3.4    Switzerland
                  7.3.5    Rest-of-Europe
         7.4    Asia Pacific
                  7.4.1    Japan
                  7.4.2    China
                  7.4.3    South Korea
                  7.4.4    India
                  7.4.5    Rest-of-Asia-Pacific
         7.5    Rest-of-the-World (RoW)

8 Company Profiles

         8.1    AbbVie Inc.
                  8.1.1    Abbvie Inc. : Overview
                  8.1.2    Abbvie Inc.: Overall Product Portfolio
                              8.1.2.1    Product Offerings for Global Biologics Drug Development Market
                  8.1.3    Financials
                              8.1.3.1    Financial Summary
                  8.1.4    SWOT Analysis
         8.2    Allergan
                  8.2.1    Allergan Plc: Overview
                  8.2.2    Allergan Plc: Overall Product Portfolio
                              8.2.2.1    Product Offerings for Global Biologics Drug Development Market
                  8.2.3    Financials
                              8.2.3.1    Financial Summary
                  8.2.4    SWOT Analysis
         8.3    Amgen, Inc.
                  8.3.1    Amgen, Inc.: Overview
                  8.3.2    Amgen, Inc.: Overall Product Portfolio
                              8.3.2.1    Product Offerings for Global Biologics Drug Development Market
                  8.3.3    Financials
                              8.3.3.1    Financial Summary
                  8.3.4    SWOT Analysis
         8.4    Boehringer Ingelheim International GmbH
                  8.4.1    Boehringer Ingelheim International GmbH: Overview
                  8.4.2    Boehringer Ingelheim International GmbH: Overall Product Portfolio
                              8.4.2.1    Product Offerings for Global Biologics Drug Development Market
                  8.4.3    Financials
                              8.4.3.1    Financial Summary
                  8.4.4    SWOT Analysis
         8.5    Catalent Inc.
                  8.5.1    Catalent Inc.: Overview
                  8.5.2    Catalent Inc.: Overall Product Portfolio
                              8.5.2.1    Product Offerings for Global Biologics Drug Development Market
                  8.5.3    Financials
                              8.5.3.1    Financial Summary
                  8.5.4    SWOT Analysis
         8.6    Charles River Laboratories
                  8.6.1    Charles River Laboratories: Overview
                  8.6.2    Charles River Laboratories: Overall Product Portfolio
                              8.6.2.1    Product Offerings for Global Biologics Drug Development Market
                  8.6.3    Financials
                              8.6.3.1    Financial Summary
                  8.6.4    SWOT Analysis
         8.7    FUJIFILM Diosynth Biotechnologies U.S.A., Inc
                  8.7.1    FUJIFILM Diosynth Biotechnologies U.S.A., Inc: Overview
                  8.7.2    FUJIFILM Holdings Corporation: Parent Company Overview
                  8.7.3    FUJIFILM Holdings Corporation: Overall Product Portfolio
                              8.7.3.1    Product Offerings for Global Biologics Drug Development Market
                  8.7.4    Financials
                              8.7.4.1    Financial Summary
                  8.7.5    SWOT Analysis
         8.8    KBI  Biopharma
                  8.8.1    KBI Biopharma: Overview
                  8.8.2    Corporate Summary
                  8.8.3    Product Offerings for Global Biologics Drug Development Market
                  8.8.4    SWOT Analysis
         8.9    Lonza
                  8.9.1    Lonza: Overview
                  8.9.2    Lonza: Overall Product Portfolio
                              8.9.2.1    Product Offerings for Global Biologics Drug Development Market
                  8.9.3    Financials
                              8.9.3.1    Financial Summary
                  8.9.4    SWOT Analysis
        8.10   MabPlex Inc.
                  8.10.1    MabPlex Inc.: Overview
                  8.10.2    Corporate Summary
                  8.10.3    Product Offerings for Global Biologics Drug Development Market
                  8.10.4    SWOT Analysis
        8.11   Patheon
                  8.11.1    Patheon: Overview
                  8.11.2    Thermo Fisher Scientific, Inc.: Parent Company Overview
                  8.11.3    Thermo Fisher Scientific, Inc.: Overall Product Portfolio
                                8.11.3.1    Product Offerings for Global Biologics Drug Development Market
                  8.11.4    Thermo Fisher Scientific: Financials
                                8.11.4.1    Financial Summary
                  8.11.5    SWOT Analysis
        8.12   Samsung BioLogics
                  8.12.1    Samsung BioLogics: Overview
                  8.12.2    Samsung BioLogics: Overall Product Portfolio
                                8.12.2.1    Product Offerings for Global Biologics Drug Development Market
                  8.12.3    Financials
                                8.12.3.1    Financial Summary
                  8.12.4    SWOT Analysis
       8.13   SANOFI
                  8.13.1    SANOFI: Overview
                  8.13.2    SANOFI: Overall Product Portfolio
                                8.13.2.1    Product Offerings for Global Biologics Drug Development Market
                  8.13.3    Financials
                                8.13.3.1    Financial Summary
                  8.13.4    SWOT Analysis
        8.14   Singota Solutions
                  8.14.1    Singota Solutions: Overview
                  8.14.2    Corporate Summary
                  8.14.3    Product Offerings for Global Biologics Drug Development Market
                  8.14.4    SWOT Analysis
        8.15   WuXi Biologics
                  8.15.1    WuXi Biologics: Overview
                  8.15.2    WuXi Biologics: Overall Product Portfolio
                                8.15.2.1    Product Offerings for Global Biologics Drug Development Market
                  8.15.3    Financials
                                8.15.3.1    Financial Summary
                  8.15.4    SWOT Analysis

Table
of Contents

You may also like

Published Year: 2017

Global Biologics Drug Discovery Market - Analysis and Forecast (2017-2025): (Focus on Method/Phase, Product Type, Manufacturer Type and Competitive Landscape)

The global biologics drug discovery market was estimated to be $8.9 billion in 2016 and is...

 
Published Year: 2017

Global Biologics Market - Analysis and Forecast (2017-2025): (Focus on Pipeline Analysis, Product Type, Therapeutic Application, Country Analysis, and Market Dynamics)

The global biologics market generated a revenue of $238.8 billion in 2016. Introduction of...

 

Global Biologics Drug Development Market

Focus on Facility, Service, Product Type, Country Analysis, and Market Dynamics - Analysis and Forecast, 2018-2027